Brad L. Gower,Jae Han Park,Clifford J. Herman,Tsz Chung Lai,Kai Feng
申请号：
US15417541
公开号：
US20170224826A1
申请日:
2017.01.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition provides extended release of the API and has abuse deterrent features.
